|4Dec 26, 9:53 PM ET

Birx Deborah 4

4 · Armata Pharmaceuticals, Inc. · Filed Dec 26, 2023

Insider Transaction Report

Form 4
Period: 2023-12-21
Birx Deborah
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2023-12-21+200,000200,000 total
  • Award

    Stock Options (Right to Buy)

    2023-12-21+200,000200,000 total
    Exercise: $2.39Exp: 2033-12-21Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the Stock Options shall vest on July 10th of each of 2024, 2025, 2026, and 2027.

Documents

1 file
  • 4
    tm2333426-7_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT